Clinical trials: Untreated Adult Acute Myeloid Leukemia

Cancer

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

• Completed
• Age: Up to 65 years
• Surgery or procedure

RATIONALE: Bone marrow transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells.

Trial name

NCT00003538

Testing

graft versus host disease prophylaxis/therapy, allogeneic bone marrow transplantation

Where

United States

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins